City

Bethesda (1)

Shanghai (1)

Tianjin (1)

Overall Status

Recruiting (2)

Completed (1)

Unknown status (1)

Phase

n/a (1)

phase 2 (1)

phase 4 (1)

Sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

Rambam Health Care Campus (1)

Shanghai Zhongshan Hospital (1)

Tianjin Medical University (1)

Collaborator

Peking Union Medical College Hospital (1)

Peking University First Hospital (1)

Zhongshan Ophthalmic Center, Sun Yat-sen University (1)

Intervention

placebo (2)

combined (1)

dexamethasone (1)

metformin (1)

methylprednisolone injection (1)

mifepristone (1)

prednisone (1)

spironolactone (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (3)

NIH (1)

Study Type

Interventional (3)

Observational (1)

glucocorticoid

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Methylprednisolone, Glucocorticoid, Aortic Dissection Trial (Methylprednisolone Injection)

Recruiting

Methylprednisolone
+3 more

Methylprednisolone Injection

Shanghai, Shanghai, China

Zhongshan Hospital

Oct 25, 2022

Uveitis, Metformin, Glucocorticoid Trial in Tianjin (Metformin, Placebo)

Recruiting

Uveitis
+2 more

Metformin
Placebo

Tianjin, Tianjin, China

Tianjin Medical University Eye Hospital

May 5, 2022

Cortisol Resistance, Negative Feedback, ACTH Trial run by the NICHD (Mifepristone, Placebo, Spironolactone)

Completed

Has Results

Cortisol Resistance
+4 more

Mifepristone
+4 more

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Oct 19, 2017

Serum FFA Desaturase Activity Index in Patients on High Dose

Unknown status

Glucocorticoid

Prednisone

(no location specified)

Aug 18, 2016